Literature DB >> 18353714

Changing HCV genotypes distribution in Poland--relation to source and time of infection.

Slawomir Chlabicz1, Robert Flisiak, Oksana Kowalczuk, Anna Grzeszczuk, Barbara Pytel-Krolczuk, Danuta Prokopowicz, Lech Chyczewski.   

Abstract

BACKGROUND: Understanding the distribution of HCV genotypes has implications for prognosis and therapy of hepatitis C.
OBJECTIVES: To describe the distribution of HCV genotypes in Poland in relation to route of transmission and year of infection. STUDY
DESIGN: Patients with chronic liver disease were evaluated at the Department of Infectious Diseases, Bialystok (Poland). HCV genotype was determined by means of 5'UTR sequencing and comparison with known sequences of particular genotypes.
RESULTS: The genotypes mostly frequently detected were genotype 1 (57.5%); genotype 3 (31.3%); and genotype 4 (8.4%). Genotype 1 constituted the majority of HCV infections caused by blood transfusion (68.8%) and only 34.8% of HCV infections in the intravenous drug use (IVDU) group (p<0.05). In contrast genotype 3 constituted the majority of HCV infections in the IVDU group (56.5%). We observed a significant increase in the proportion of genotype 3 infections detected after 2000--from 19.1% to 38.9%.
CONCLUSIONS: The relative proportion of genotype 1b in Poland has decreased and that of genotype 3a has increased, especially among IVDU.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18353714     DOI: 10.1016/j.jcv.2008.02.001

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  20 in total

1.  Characteristics of chronic hepatitis C among intravenous drug users: a comparative analysis.

Authors:  Maja Jovanović; Branislav Jovanović; Milena Potić; Ljiljana Konstantinović; Miodrag Vrbić; Biljana Radovanović-Dinić; Velimir Kostić
Journal:  Bosn J Basic Med Sci       Date:  2010-05       Impact factor: 3.363

Review 2.  Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes.

Authors:  Simona Ruta; Costin Cernescu
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

3.  Hepatitis C viremia and genotype distribution among a sample of nonmedical prescription drug users exposed to HCV in rural Appalachia.

Authors:  April M Young; Richard A Crosby; Carrie B Oser; Carl G Leukefeld; Dustin B Stephens; Jennifer R Havens
Journal:  J Med Virol       Date:  2012-09       Impact factor: 2.327

Review 4.  Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.

Authors:  Filippo Ansaldi; Andrea Orsi; Laura Sticchi; Bianca Bruzzone; Giancarlo Icardi
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

5.  HCV genotype distribution in Flanders and Brussels (Belgium): unravelling the spread of an uncommon HCV genotype 5a cluster.

Authors:  J Verbeeck; L Kwanten; F D'Heygere; A Beguin; S Michiels; I Desombere; G Leroux-Roels; P Lemey; F Nevens; M Van Ranst
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-10       Impact factor: 3.267

6.  Change in hepatitis C virus clades: a cross-sectional study of chronic HCV patients in Pakistan from 2000-2010.

Authors:  S Butt; M Idrees; M Shahid; I Amin; S Younas; S Afzal; H Akbar; I Ur Rehman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-06       Impact factor: 3.267

7.  HEPATITIS C VIRUS GENOTYPES IN INJECTING DRUG USERS FROM ROMANIA.

Authors:  Camelia Sultana; Codruta Vagu; Aura Temereanca; Camelia Grancea; Josefina Slobozeanu; Simona Ruta
Journal:  Cent Eur J Med       Date:  2011-10

Review 8.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

Review 9.  Epidemiology and natural history of HCV infection.

Authors:  Behzad Hajarizadeh; Jason Grebely; Gregory J Dore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-02       Impact factor: 46.802

10.  Distribution of hepatitis C virus genotypes in Iranian chronic infected patients.

Authors:  Fatemeh Jahanbakhsh Sefidi; Hossein Keyvani; Seyed Hamidreza Monavari; Seyed Moayed Alavian; Shahin Fakhim; Farah Bokharaei-Salim
Journal:  Hepat Mon       Date:  2013-01-20       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.